Biotech Opportunities And Risks In Q2 – And Beyond

After a challenging first quarter of 2021 for biotech investors, what does the second quarter – and, beyond that, the second half of 2021 – have in store? Today’s article examines the investment opportunities the space offers at both ends of the disease prevalence spectrum, as well as the potential risks at play. For more, CLICK HERE.